These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 28334867)

  • 1. The silent mutation MLH1 c.543C>T resulting in aberrant splicing can cause Lynch syndrome: a case report.
    Yamaguchi T; Wakatsuki T; Kikuchi M; Horiguchi SI; Akagi K
    Jpn J Clin Oncol; 2017 Jun; 47(6):576-580. PubMed ID: 28334867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant splicing in MLH1 and MSH2 due to exonic and intronic variants.
    Pagenstecher C; Wehner M; Friedl W; Rahner N; Aretz S; Friedrichs N; Sengteller M; Henn W; Buettner R; Propping P; Mangold E
    Hum Genet; 2006 Mar; 119(1-2):9-22. PubMed ID: 16341550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel frameshift mutation in the
    Pandey AS; Shrestha S
    Indian J Cancer; 2018; 55(4):410-412. PubMed ID: 30829280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An intronic mutation in MLH1 associated with familial colon and breast cancer.
    Bianchi F; Raponi M; Piva F; Viel A; Bearzi I; Galizia E; Bracci R; Belvederesi L; Loretelli C; Brugiati C; Corradini F; Baralle D; Cellerino R
    Fam Cancer; 2011 Mar; 10(1):27-35. PubMed ID: 20717847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population.
    Lagerstedt-Robinson K; Rohlin A; Aravidis C; Melin B; Nordling M; Stenmark-Askmalm M; Lindblom A; Nilbert M
    Oncol Rep; 2016 Nov; 36(5):2823-2835. PubMed ID: 27601186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a germline splice site variant MLH1 c.678-3T>A in a Lynch syndrome family.
    Yang C; Sheehan M; Borras E; Cadoo K; Offit K; Zhang L
    Fam Cancer; 2020 Oct; 19(4):315-322. PubMed ID: 32356167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutional MLH1 methylation presenting with colonic polyposis syndrome and not Lynch syndrome.
    Kidambi TD; Blanco A; Van Ziffle J; Terdiman JP
    Fam Cancer; 2016 Apr; 15(2):275-80. PubMed ID: 26781822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
    Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
    Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Null pattern" of immunoreactivity in a Lynch syndrome-associated colon cancer due to germline MSH2 mutation and somatic MLH1 hypermethylation.
    Hagen CE; Lefferts J; Hornick JL; Srivastava A
    Am J Surg Pathol; 2011 Dec; 35(12):1902-5. PubMed ID: 22067334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian metastasis from uveal melanoma with MLH1/PMS2 protein loss in a patient with germline MLH1 mutated Lynch syndrome: consequence or coincidence?
    Lobo J; Pinto C; Freitas M; Pinheiro M; Vizcaino R; Oliva E; Teixeira MR; Jerónimo C; Bartosch C
    Virchows Arch; 2017 Mar; 470(3):347-352. PubMed ID: 27915441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PMS2 involvement in patients suspected of Lynch syndrome.
    Niessen RC; Kleibeuker JH; Westers H; Jager PO; Rozeveld D; Bos KK; Boersma-van Ek W; Hollema H; Sijmons RH; Hofstra RM
    Genes Chromosomes Cancer; 2009 Apr; 48(4):322-9. PubMed ID: 19132747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Founder mutation in Lynch syndrome].
    Cajal AR; Piñero TA; Verzura A; Santino JP; Solano AR; Kalfayan PG; Ferro A; Vaccaro C
    Medicina (B Aires); 2016; 76(3):180-2. PubMed ID: 27295708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological exon skipping in an HNPCC proband with MLH1 splice acceptor site mutation.
    Clarke LA; Veiga I; Isidro G; Jordan P; Ramos JS; Castedo S; Boavida MG
    Genes Chromosomes Cancer; 2000 Dec; 29(4):367-70. PubMed ID: 11066084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.
    Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T
    Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudomyxoma peritonei of a mature ovarian teratoma caused by mismatch repair deficiency in a patient with Lynch syndrome: a case report.
    Gohda Y; Noguchi R; Horie T; Igari T; Nakamura H; Ohta Y; Yamaguchi K; Ikenoue T; Hatakeyama S; Yusa N; Furukawa Y; Yano H
    BMC Med Genet; 2016 Dec; 17(1):94. PubMed ID: 27938333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and presymptomatic analysis of a Moroccan Lynch syndrome family revealed a novel frameshift MLH1 germline mutation.
    Moufid FZ; Bouguenouch L; El Bouchikhi I; Houssaini MI; Ouldim K
    Turk J Gastroenterol; 2018 Nov; 29(6):701-704. PubMed ID: 30289396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome).
    Hendriks YM; Jagmohan-Changur S; van der Klift HM; Morreau H; van Puijenbroek M; Tops C; van Os T; Wagner A; Ausems MG; Gomez E; Breuning MH; Bröcker-Vriends AH; Vasen HF; Wijnen JT
    Gastroenterology; 2006 Feb; 130(2):312-22. PubMed ID: 16472587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy.
    Najdawi F; Crook A; Maidens J; McEvoy C; Fellowes A; Pickett J; Ho M; Nevell D; McIlroy K; Sheen A; Sioson L; Ahadi M; Turchini J; Clarkson A; Hogg R; Valmadre S; Gard G; Dooley SJ; Scott RJ; Fox SB; Field M; Gill AJ
    Pathology; 2017 Aug; 49(5):457-464. PubMed ID: 28669579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRAF V600E-specific immunohistochemistry for the exclusion of Lynch syndrome in MSI-H colorectal cancer.
    Capper D; Voigt A; Bozukova G; Ahadova A; Kickingereder P; von Deimling A; von Knebel Doeberitz M; Kloor M
    Int J Cancer; 2013 Oct; 133(7):1624-30. PubMed ID: 23553055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive functional assessment of MLH1 variants of unknown significance.
    Borràs E; Pineda M; Brieger A; Hinrichsen I; Gómez C; Navarro M; Balmaña J; Ramón y Cajal T; Torres A; Brunet J; Blanco I; Plotz G; Lázaro C; Capellá G
    Hum Mutat; 2012 Nov; 33(11):1576-88. PubMed ID: 22736432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.